Core Viewpoint - A securities class action lawsuit has been filed against Enphase Energy, alleging that the company made false or misleading statements regarding its financial and operational prospects during the class period from February 25, 2025, to February 2, 2026 [1]. Group 1: Allegations - The lawsuit claims that Enphase Energy overstated its ability to manage channel inventory [2]. - It is alleged that the company exaggerated its capacity to mitigate the effects of the termination of the Residential Clean Energy Credit under Internal Revenue Code Section 25D [2]. - The complaint states that these misrepresentations led to an overstatement of the company's financial and operational prospects [2]. Group 2: Financial Impact - On October 28, 2025, Enphase Energy reported third-quarter financial results, indicating that elevated channel inventory would lead to lower battery storage shipments in the fourth quarter of 2025 [2]. - The expiration of the 25D Credit was expected to negatively impact revenues for the first quarter of 2026 [2]. - Following this announcement, the company's stock price fell by more than 15% [2]. Group 3: Legal Proceedings - Investors who acquired shares of Enphase Energy during the class period are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline on April 20, 2026 [3].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Plug Power Inc. securities during the specified Class Period, indicating potential legal issues surrounding the company's disclosures and financial statements [1][5]. Group 1: Class Action Details - The class action lawsuit is for purchasers of Plug Power securities between January 17, 2025, and November 13, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must move the Court by April 3, 2026, to represent other class members in the litigation [3]. Group 2: Allegations Against Plug Power - The lawsuit alleges that defendants made false and misleading statements regarding the availability of funds from the U.S. Department of Energy's Loan and the construction of hydrogen production facilities [5]. - It is claimed that Plug Power was likely to pivot towards less ambitious projects with lower commercial potential, contradicting earlier public statements [5]. - The lawsuit asserts that these misleading statements resulted in investor damages when the true information became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing investor rights [4].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183202&from=4 CLASS PERIOD: July 18, 202 ...

Core Viewpoint - A second securities class action has been filed against Coupang, Inc. expanding the Class Period to include investors who purchased securities between May 7, 2025, and December 16, 2025, with a Lead Plaintiff Deadline set for February 17, 2026 [1][3]. Group 1: Allegations and Investigations - The firm is investigating Coupang's statements regarding its disclosure controls, cybersecurity protocols, and transparency related to a data breach that allegedly allowed a former employee to access sensitive customer data [2][7]. - The complaint focuses on Coupang's assurances to investors about its disclosure controls and the absence of material changes in risk factors that could adversely affect the business [4][5]. Group 2: Timeline of Events - Coupang filed its quarterly report on May 6, 2025, assuring investors of sufficient disclosure controls and no material changes in risk factors [4]. - On June 30, 2025, Coupang issued a privacy notice to Korean customers, claiming technical and administrative safeguards were in place to protect personal information [4]. - On November 29, 2025, Coupang revealed unauthorized access to about 4,500 customer accounts, later confirming that approximately 33.7 million accounts were affected [5][6]. Group 3: Financial Impact - Following the breach announcement, Coupang's market capitalization decreased by over $8 billion [6]. - On December 29, 2025, Coupang announced a compensation plan of 1.685 trillion won (over $1 billion) aimed at restoring customer trust [6].

Core Viewpoint - A securities class action lawsuit has been filed against CarMax, Inc. for allegedly misleading investors regarding the company's financial health and operational performance during the specified class period from June 20, 2025, to November 5, 2025 [1] Group 1: Allegations - The Complaint alleges that CarMax failed to disclose underperformance of its 2022 and 2023 vintage loans [2] - It is claimed that CarMax's loss reserves were inadequate to cover the underperforming loans [2] - The company reportedly had an oversupply of vehicles in early 2025, leading to significant depreciation of its inventory [2] - The sales boost in mid-2025 was primarily driven by customers purchasing used cars due to concerns over potential new-car tariffs [2] - The allegations suggest that CarMax materially overstated customer receivables, inventory values, and earnings, misleading investors about its business and growth prospects [2] Group 2: Stock Price Impact - The truth about CarMax's financial situation emerged through two corrective disclosures, the first being on September 25, 2025, when the company reported weak fiscal Q2 2026 results, leading to a 20.1% drop in stock price [3] - The second disclosure occurred on November 4, 2025, when CarMax announced the termination of CEO William Nash and warned of a sharp decline in used-car sales, resulting in an additional 24.3% decline in stock price [3]

Core Points - Stride, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from October 22, 2024, to October 28, 2025 [1][3] - The lawsuit is pending in the United States District Court for the Eastern District of Virginia, and investors have until January 12, 2026, to file lead plaintiff applications [1][6] Company Issues - On September 14, 2025, Gallup-McKinley County Schools Board of Education filed a complaint against Stride, alleging fraud and deceptive trade practices, including inflating enrollment numbers by retaining "ghost students" [4] - Following this news, Stride's share price dropped by $18.60, or 11.7%, closing at $139.76 on September 15, 2025 [4] - On October 28, 2025, Stride disclosed that "poor customer experience" led to higher withdrawal rates and lower conversion rates, resulting in an estimated 10,000-15,000 fewer enrollments, which negatively impacted the company's outlook [5] - This announcement caused Stride's share price to plummet by $83.48, or over 54%, closing at $70.05 on October 29, 2025 [5]

Core Viewpoint - Rosen Law Firm is urging investors of Jasper Therapeutics, Inc. to contact them regarding a class action lawsuit due to allegations of misleading business operations [1][2]. Summary by Sections Allegations - The lawsuit claims that Jasper Therapeutics made false and misleading statements, including: - Lack of necessary controls and procedures for third-party manufacturers to comply with cGMP regulations [3]. - Increased risk of confounding results in ongoing studies, negatively impacting regulatory and commercial prospects of products like briquilimab [3]. - Potential for disruptive cost-reduction measures due to the aforementioned failures [3]. - Overstated business and financial prospects, as well as clinical and commercial prospects of briquilimab [3]. - Public statements made by defendants were materially false and misleading [3]. Class Action Participation - Investors may be eligible to participate in the class action against Jasper Therapeutics, with a deadline to file motions for lead plaintiff by November 18, 2025 [4]. - Investors do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4]. Rosen Law Firm Background - Rosen Law Firm is recognized for its commitment to shareholder rights litigation, having recovered over $1 billion for shareholders since its inception [6].

Core Viewpoint - KBR, Inc. is facing a securities class action lawsuit for failing to disclose material information during the specified Class Period, which has resulted in significant stock price declines following negative news related to a joint venture with HomeSafe Alliance [3][4]. Summary by Sections Lawsuit Details - The lawsuit is titled Norrman v. KBR, Inc., et al., No. 25-cv-04464, and is pending in the United States District Court for the Southern District of Texas [5]. - Investors who purchased KBR securities between May 6, 2025, and June 19, 2025, have until November 18, 2025, to file lead plaintiff applications [1][2]. Stock Price Impact - On June 19, 2025, KBR's joint venture, HomeSafe, announced the termination of a significant contract with the U.S. Department of Defense, leading to a drop in KBR's stock price by $3.85, or 7.29%, closing at $48.93 on June 20, 2025 [4]. - The stock experienced further decline, falling an additional $1.30, or 2.65%, to close at $47.63 on June 23, 2025 [4]. Company Background - KBR, Inc. has a 72% economic interest in HomeSafe Alliance, which was awarded a contract in 2021 to improve the military move system [4]. - Kahn Swick & Foti, LLC (KSF) is a prominent law firm specializing in securities litigation, representing various investors seeking recoveries for losses due to corporate fraud [5].

Core Viewpoint - A class action lawsuit has been filed against Snap Inc. for alleged violations of securities laws, specifically related to misleading statements about the impact of Apple's privacy changes on its advertising business [1][4]. Group 1: Lawsuit Details - The lawsuit is based on claims that Snap made false and misleading statements regarding its advertising capabilities in light of Apple's device privacy changes [4]. - The class period for the lawsuit is defined as between July 22, 2020, and October 21, 2021 [2]. - Investors who suffered losses during this period are encouraged to participate in the lawsuit before the deadline of January 10, 2021 [2]. Group 2: Company Statements - Snap allegedly downplayed the risks posed by Apple's privacy changes and overstated its commitment to user privacy [4]. - The company's public statements are claimed to have been materially misleading, leading to investor damages when the truth was revealed [4]. Group 3: Legal Representation - The Schall Law Firm specializes in securities class action lawsuits and is representing investors globally [5]. - Investors can contact the firm for a free discussion of their rights [3].

Core Viewpoint - A securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. for failing to disclose material information during its October 2024 IPO, with a deadline for lead plaintiff applications set for October 13, 2025 [1][2][3]. Company Information - KinderCare Learning Companies, Inc. is facing allegations related to its IPO Registration Statement and Prospectus, claiming violations of federal securities laws [3]. - The lawsuit is identified as Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 [5]. Allegations - The lawsuit alleges that KinderCare failed to disclose numerous incidents of child abuse, neglect, and harm at its facilities [4]. - It is claimed that the company did not provide the "highest quality care possible" and failed to meet basic standards in the child care industry, exposing it to undisclosed risks of lawsuits and reputational damage [4]. Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the plaintiffs in this case [6]. - The firm has been recognized among the top 10 firms nationally based on total settlement value, indicating its significant role in securities litigation [6].